MINNEAPOLIS--(BUSINESS WIRE)--Urologix®, Inc. (NASDAQ:ULGX), today reported financial results for the fiscal 2008 first quarter ended September 30, 2007. Revenue for the first quarter was $4.4 million, which is 20 percent lower than $5.4 million reported in the same period of fiscal 2007 and 10 percent less than $4.8 million reported in the fourth quarter of fiscal 2007. The revenue decline is driven primarily by reduced orders from direct office customers. During the first quarter, procedure kit average selling prices (ASPs) improved 2 percentage points from the prior quarter. Revenue from catheter sales to direct accounts constituted 46 percent of overall revenue in the first quarter of fiscal 2008 as compared to 51 percent in the fourth quarter of fiscal 2007. Third party mobile revenue represented approximately 13 percent of overall revenue compared to 9 percent of revenue in the fourth quarter of fiscal 2007. Revenue derived from the Urologix-owned Cooled ThermoTherapy mobile service constituted 40 percent of overall revenue in the first quarter of fiscal 2008 compared to 37 percent in the fourth quarter of fiscal 2007.
